您的位置: 首页 > 农业专利 > 详情页

Benzonatate modified release solid tablets and capsules
专利权人:
TRIS Pharma Inc.
发明人:
Andrea Nelson,Quin-Zene Chen,Harsh Mehta,Yu-Hsing Tu
申请号:
US15075697
公开号:
US09867797B2
申请日:
2016.03.21
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充